rs782634293
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_000169.3(GLA):c.640-11T>C variant causes a intron change. The variant allele was found at a frequency of 0.00000168 in 1,188,786 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 9.3e-7 ( 0 hom. 0 hem. )
Consequence
GLA
NM_000169.3 intron
NM_000169.3 intron
Scores
2
Splicing: ADA: 0.5274
2
Clinical Significance
Conservation
PhyloP100: 4.31
Publications
0 publications found
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant X-101398957-A-G is Benign according to our data. Variant chrX-101398957-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 237124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000889 AC: 1AN: 112434Hom.: 0 Cov.: 24 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
112434
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000545 AC: 1AN: 183346 AF XY: 0.0000147 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
183346
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 9.29e-7 AC: 1AN: 1076352Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 343480 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1076352
Hom.:
Cov.:
29
AF XY:
AC XY:
0
AN XY:
343480
show subpopulations
African (AFR)
AF:
AC:
0
AN:
25988
American (AMR)
AF:
AC:
0
AN:
35187
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19227
East Asian (EAS)
AF:
AC:
0
AN:
30120
South Asian (SAS)
AF:
AC:
0
AN:
53500
European-Finnish (FIN)
AF:
AC:
0
AN:
40507
Middle Eastern (MID)
AF:
AC:
0
AN:
3128
European-Non Finnish (NFE)
AF:
AC:
1
AN:
823326
Other (OTH)
AF:
AC:
0
AN:
45369
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00000889 AC: 1AN: 112434Hom.: 0 Cov.: 24 AF XY: 0.0000289 AC XY: 1AN XY: 34580 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
112434
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34580
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30943
American (AMR)
AF:
AC:
0
AN:
10568
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2653
East Asian (EAS)
AF:
AC:
0
AN:
3604
South Asian (SAS)
AF:
AC:
0
AN:
2727
European-Finnish (FIN)
AF:
AC:
0
AN:
6153
Middle Eastern (MID)
AF:
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
AC:
1
AN:
53351
Other (OTH)
AF:
AC:
0
AN:
1512
Age Distribution
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Fabry disease Benign:3
Sep 26, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 16, 2019
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 15, 2023
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Mar 26, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -11
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.